Anti-Myc and Anti-DDK monoclonal antibodies |
|||
| E45M08809V-2 | EnoGene | 50 ul | EUR 195 |
Bioss Antibodies Laboratories manufactures the biioss reagents distributed by Genprice. The Biioss reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Bioss Antibodies. Other Biioss products are available in stock. Specificity: Biioss Category:
True Blue Chloride |
||
| Toronto Research Chemicals | 100mg | EUR 11200 |
|
Description: 71431-30-6 |
||
True north Cryobox1.5/2mLNatural |
||
| Scientific Laboratory Supplies | PK10 | EUR 129.6 |
True Blue Diaceturate Salt |
||
| Toronto Research Chemicals | 100mg | EUR 15000 |
|
Description: 108321-12-6 |
||
Anti-Myc and Anti-DDK monoclonal antibodies |
||
| EnoGene | 50 ul | EUR 195 |
Goat and Sheep Toxoplasmosis Antibodies ELISA Kit |
||
| MyBiosource | 10x96Tests | EUR 2650 |
Goat and Sheep Toxoplasmosis Antibodies ELISA Kit |
||
| MyBiosource | 24Tests | EUR 225 |
Goat and Sheep Toxoplasmosis Antibodies ELISA Kit |
||
| MyBiosource | 48Test | EUR 315 |
BIIB 021 |
|||
| MBS6104269-5x50mg | MyBiosource | 5x50mg | EUR 2600 |
BIIL 260 |
|||
| T26809-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: BIIL 260 |
|||
BIIL 260 |
|||
| T26809-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: BIIL 260 |
|||
BIIL 260 |
|||
| T26809-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: BIIL 260 |
|||
BIIL 260 |
|||
| T26809-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: BIIL 260 |
|||
BIIL 260 |
|||
| T26809-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: BIIL 260 |
|||
BIIB021 |
|||
| 27046 | BPS Bioscience | 5 mg | EUR 130 |
|
Description: BIIB021 is an orally available, synthetic small-molecule Hsp90 inhibitor. It binds in the ATP-binding pocket of Hsp90 (Ki = 1.7 ± 0.4 nM) and induces HER-2 degradation with an EC50 of 38 ± 10 nM in MCF-7 cells. It ncreases expression of the heat shock proteins Hsp90α and Hsp70, but has no effect on expression of the nonclient protein phosphatidylinositol 3-kinase p85 subunit. BIIB021 inhibits the proliferation of N87, MCF-7, and BT474 tumor cells with IC50 values of 0.06, 0.31, and 0.14 µM, respectively. It has significant antitumor activity in N87 stomach, BT474 breast, CWR22 prostate, U87 glioblastoma, SKOV3 ovarian, and Panc-1 pancreatic tumor xenograft models. |
|||
BIIB021 |
|||
| 200505 | MedKoo Biosciences | 10.0mg | EUR 150 |
Biib-021 |
|||
| abx188616-1g | Abbexa | 1 g | EUR 910.8 |
BIIB021 |
|||
| abx188616-96tests | Abbexa | 96 tests | EUR 118.75 |
BIIB021 |
|||
| A4058-10 | ApexBio | 10 mg | EUR 64 |
|
Description: Metabolism|HSP#Proteases|HSP |
|||
BIIB021 |
|||
| A4058-100 | ApexBio | 100 mg | EUR 256 |
|
Description: Metabolism|HSP#Proteases|HSP |
|||
BIIB021 |
|||
| A4058-5 | ApexBio | 5 mg | EUR 44 |
|
Description: Metabolism|HSP#Proteases|HSP |
|||
BIIB021 |
|||
| A4058-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 48.8 |
|
Description: Metabolism|HSP#Proteases|HSP |
|||
BIIB021 |
|||
| A4058-50 | ApexBio | 50 mg | EUR 168 |
|
Description: Metabolism|HSP#Proteases|HSP |
|||
BIIB068 |
|||
| 462609 | MedKoo Biosciences | 50.0mg | EUR 950 |
BIIB021 |
|||
| HY-10212 | MedChemExpress | 50mg | EUR 250 |
|
Description: BIIB021 (CNF2024) is an orally active, fully synthetic inhibitor of HSP90 with a Ki and an EC50 of 1.7 nM and 38 nM, respectively[1]. |
|||